{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T17:32:28Z","timestamp":1787851948628,"version":"build-2784847793"},"reference-count":60,"publisher":"Informa UK Limited","issue":"12","license":[{"start":{"date-parts":[[2020,12,11]],"date-time":"2020-12-11T00:00:00Z","timestamp":1607644800000},"content-version":"unspecified","delay-in-days":45,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Opinion on Investigational Drugs"],"published-print":{"date-parts":[[2020,12,1]]},"DOI":"10.1080\/13543784.2020.1839888","type":"journal-article","created":{"date-parts":[[2020,10,19]],"date-time":"2020-10-19T12:56:06Z","timestamp":1603112166000},"page":"1365-1375","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":71,"title":["The nonalcoholic steatohepatitis (NASH) drug development graveyard: established hurdles and planning for future success"],"prefix":"10.1080","volume":"29","author":[{"given":"Joost P.H.","family":"Drenth","sequence":"first","affiliation":[{"name":"Department of Gastroenterology and Hepatology, Radboud University Medical Centre, Nijmegen, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4224-4703","authenticated-orcid":false,"given":"J\u00f6rn M.","family":"Schattenberg","sequence":"additional","affiliation":[{"name":"Department of Medicine, University Medical Centre of the Johannes Gutenberg-University, Mainz, Germany"},{"name":"Metabolic Liver Research Program, University Medical Centre of the Johannes Gutenberg-University, Mainz, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2020,10,27]]},"reference":[{"key":"cit0001","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2020.01.052"},{"key":"cit0002","unstructured":"Shetty A, Syn WK. Health and economic burden of nonalcoholic fatty liver disease in the United States and its impact on veterans. Federal practitioner: for the health care professionals of the VA, DoD, and PHS. 2019;36(1):14\u201319."},{"key":"cit0003","unstructured":"[cited 2020 Oct 23]. Available from: https:\/\/www.reportsanddata.com\/report-detail\/non-alcoholic-steatohepatitis-nash-market"},{"key":"cit0004","doi-asserted-by":"publisher","DOI":"10.1016\/S0168-8278(18)30425-2"},{"key":"cit0005","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2020.02.020"},{"key":"cit0006","doi-asserted-by":"publisher","DOI":"10.1111\/apt.14976"},{"key":"cit0007","doi-asserted-by":"publisher","DOI":"10.1002\/hep.31158"},{"key":"cit0008","doi-asserted-by":"publisher","DOI":"10.1111\/apt.15738"},{"key":"cit0009","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2016.06.026"},{"key":"cit0010","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2020-321964"},{"key":"cit0011","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2017.12.001"},{"key":"cit0012","doi-asserted-by":"publisher","DOI":"10.1002\/hep.29085"},{"key":"cit0013","doi-asserted-by":"publisher","DOI":"10.1002\/hep.30333"},{"key":"cit0014","doi-asserted-by":"publisher","DOI":"10.1007\/s10620-019-05986-9"},{"key":"cit0015","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2020.01.043"},{"key":"cit0016","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(19)33041-7"},{"issue":"6","key":"cit0017","first-page":"317","volume":"15","author":"Younossi Z","year":"2019","journal-title":"Gastroenterol Hepatol"},{"key":"cit0018","doi-asserted-by":"publisher","DOI":"10.1097\/MOL.0000000000000599"},{"key":"cit0019","doi-asserted-by":"publisher","DOI":"10.1016\/S0168-8278(18)30221-6"},{"key":"cit0020","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2020.02.027"},{"key":"cit0021","doi-asserted-by":"publisher","DOI":"10.1002\/hep.29514"},{"key":"cit0022","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2020.04.034"},{"key":"cit0023","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2018.07.006"},{"key":"cit0024","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhepr.2019.100064"},{"key":"cit0025","unstructured":"[cited 2020 Oct 23]. Available from: https:\/\/www.globenewswire.com\/news-release\/2016\/09\/29\/875865\/0\/en\/Cempra-Announces-Anti-NASH-Effects-of-Solithromycin-Interim-Results-From-Phase-2-Study.html"},{"key":"cit0026","unstructured":"Sumati N. FDA Introductory Remarks NDA 209006 Solithromycin Capsules NDA 209007 Solithromycin Injection. Antimicrobial Drugs Advisory Committee Meeting. 2016 Nov 4. Available from: https:\/\/www.fda.gov\/media\/101570\/download"},{"key":"cit0027","unstructured":"[cited 2020 Oct 23]. Available from: https:\/\/seekingalpha.com\/news\/3247047-cempras-solithromycin-fails-to-match-standard-of-care-in-gc-study-development-in-nash"},{"key":"cit0028","first-page":"S396","volume":"58","author":"Wagner B","year":"2015","journal-title":"Diabetologia"},{"key":"cit0029","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2020.04.037"},{"key":"cit0030","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2018.04.042"},{"key":"cit0031","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2018.07.027"},{"key":"cit0032","unstructured":"[cited 2020 Oct 23]. Available from: https:\/\/www.novumpr.nl\/2019\/12\/16\/gilead-announces-topline-results-from-phase-2-atlas-study-in-patients-with-bridging-fibrosis-f3-and-compensated-cirrhosis-f4-due-to-nonalcoholic-steatohepatitis-nash\/"},{"key":"cit0033","doi-asserted-by":"publisher","DOI":"10.1002\/hep.31205"},{"key":"cit0034","unstructured":"[cited 2020 Oct 23]. Available from: https:\/\/www.clinicaltrialsarena.com\/news\/boehringer-drops-nash-development\/"},{"key":"cit0035","unstructured":"[cited 2020 Oct 23]. Available from: https:\/\/pipelinereview.com\/index.php\/2019022570608\/Small-Molecules\/Boehringer-Ingelheim-Completes-Enrollment-of-Phase-2a-Clinical-Trial-of-Pharmaxis-Developed-Drug-in-NASH.html"},{"key":"cit0036","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2019.12.010"},{"key":"cit0037","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2019.11.024"},{"key":"cit0038","doi-asserted-by":"publisher","DOI":"10.1080\/13543784.2020.1668375"},{"key":"cit0039","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2016.01.038"},{"key":"cit0040","unstructured":"Available from: https:\/\/pharmaphorum.com\/news\/genfits-nash-hopes-are-dashed-by-phase-3-trial-fail\/"},{"key":"cit0041","doi-asserted-by":"publisher","DOI":"10.1172\/JCI28898"},{"key":"cit0042","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmet.2018.08.005"},{"key":"cit0043","doi-asserted-by":"publisher","DOI":"10.1002\/jcb.25453"},{"key":"cit0044","doi-asserted-by":"publisher","DOI":"10.1152\/ajpgi.00304.2014"},{"key":"cit0045","doi-asserted-by":"publisher","DOI":"10.1111\/jgh.12924"},{"key":"cit0046","doi-asserted-by":"publisher","DOI":"10.1177\/2050640619865133"},{"key":"cit0047","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2010.10.009"},{"key":"cit0048","doi-asserted-by":"publisher","DOI":"10.1007\/s11901-017-0378-2"},{"key":"cit0049","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2019.12565"},{"key":"cit0050","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2020.06.025"},{"key":"cit0051","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2020.07.020"},{"key":"cit0052","doi-asserted-by":"publisher","DOI":"10.1002\/hep.30986"},{"key":"cit0053","doi-asserted-by":"publisher","DOI":"10.1002\/hep.30946"},{"key":"cit0054","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2020.01.051"},{"key":"cit0055","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2020.04.030"},{"key":"cit0056","doi-asserted-by":"publisher","DOI":"10.1111\/hepr.13425"},{"key":"cit0057","doi-asserted-by":"publisher","DOI":"10.1080\/13543784.2020.1721150"},{"key":"cit0058","doi-asserted-by":"publisher","DOI":"10.1002\/hep.29607"},{"key":"cit0059","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2020.03.039"},{"key":"cit0060","doi-asserted-by":"publisher","DOI":"10.1177\/2050640619868352"}],"container-title":["Expert Opinion on Investigational Drugs"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/13543784.2020.1839888","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,8]],"date-time":"2021-05-08T01:36:27Z","timestamp":1620437787000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/13543784.2020.1839888"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,27]]},"references-count":60,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2020,12,1]]}},"alternative-id":["10.1080\/13543784.2020.1839888"],"URL":"https:\/\/doi.org\/10.1080\/13543784.2020.1839888","relation":{},"ISSN":["1354-3784","1744-7658"],"issn-type":[{"value":"1354-3784","type":"print"},{"value":"1744-7658","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,10,27]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ieid20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ieid20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2020-09-17","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-10-18","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-10-27","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}